Pentasa tablets approved for once daily use

Pentasa (mesalazine) 500mg slow-release tablets have been licensed for once daily administration in the maintenance therapy of mild to moderate ulcerative colitis.

All oral formulations of Pentasa are now approved for once daily dosing in a maintenance setting.

View Pentasa drug record

Further information: Ferring

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

More from MIMS

Live updates: Coronavirus (COVID-19) in the UK

Live updates: Coronavirus (COVID-19) in the UK

Use our timeline to follow the latest coronavirus developments...

Drug shortages - live tracker

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

Proposed withdrawal of bipolar disorder treatment revoked

Proposed withdrawal of bipolar disorder treatment revoked

The manufacturer of first-line bipolar disorder treatment...

NICE recommends further migraine prevention option

NICE recommends further migraine prevention option

Galcanezumab (Emgality) is the second calcitonin gene-related...